Absence of clinical symptoms following the first injection of anti-T cell receptor monoclonal antibody (BMA 031) despite isolated TNF release

Transplantation. 1993 Feb;55(2):443-5. doi: 10.1097/00007890-199302000-00043.
No abstract available

MeSH terms

  • Animals
  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal / therapeutic use*
  • Humans
  • Immunosuppression Therapy
  • Kidney Transplantation*
  • Mice
  • Receptors, Antigen, T-Cell / immunology*
  • Transplantation, Homologous
  • Tumor Necrosis Factor-alpha / metabolism*

Substances

  • Antibodies, Monoclonal
  • Receptors, Antigen, T-Cell
  • Tumor Necrosis Factor-alpha